Eli Lilly News

The revolving door is the two-way conduit between leadership positions in government and industry that helps to enable health care, and maybe all of society, to be run by a group of insiders who can move easily between large or influential health care organizations and the government bodies that are supposed to regulate, oversee, and enforce laws ... (more)

Eli Lilly and Co. has filed a 101-page patent-infringement lawsuit against 35 generic drug companies to block them from selling knockoffs of a Lilly-marketed blood-thinner called Effient.

Eli Lilly and Co.' s corporate headquarters are shown at Delaware and McCarty streets in Indianapolis.

Eli Lilly and Co. has filed a 101-page patent-infringement lawsuit against 35 generic drug companies to block them from selling knockoffs of a Lilly-marketed blood-thinner called Effient.

Results of AWARD 6 trials establish shows once-weekly diabetes drug, Dulaglutide as good as same class Novo Nordisk drug, Victoza.

's stock had its "neutral" rating reiterated by Zacks in a research report issued on Tuesday, Stock Ratings News reports.

Still struggling to revive its drought of approvals, especially after staunchly refusing to succumb to the rest of Big Pharma's strategy of mergers and acquisitions, Eli Lilly suffered another setback for its diabetes pipeline this week when the FDA rejected Lilly's SGLT2 inhibitor empagliflozin, stating concern with the Boerhringer Ingelheim plant ... (more)

Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug.

Eli Lilly and partner Novast Laboratories announced they will expand manufacturing and development capabilities in Nantong, China.

Cellular Dynamics International, Inc. , a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the fourth quarter and for the fiscal year ended December 31, 2013.

Some of the nation's largest pharmaceutical companies have slashed payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a new ProPublica analysis shows.

Teva announced that its generic equivalent to Evista 60 mg tablets has been approved in the U.S. The approval makes Teva's generic version eligible for 180 days of marketing exclusivity.

People listings are free. Information must be submitted at least 11 days before the Monday issue in which it is to appear.

Ahead of a federal law that will require pharmaceutical and medical device companies to fully disclose how much money they pay physicians, a nonprofit news organization has provided patients a tool to see exactly what doctors receive and for what reason.

Indianapolis-based contemporary fine artist Taylor Smith's work documents her interest in sexuality, the human figure, science, nature, analogue photography.

Eli Lilly and Co., one of the biggest U.S. drug makers, plans to buy Germany's privately held Lohmann Animal Health for an undisclosed sum in a move to expand its animal vaccine business.a © Lilly regularly uses acquisitions to expand its animal health business, Elanco, which is one of the largest in the world.a © Lohmann, which is owned ... (more)

Some of the nation's largest pharmaceutical companies have slashed payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a new ProPublica analysis shows.

As dermatologist Dr. Robert Stokes serves a prison sentence for fraud, a former patient is cheering progress in the campaign against the reuse of syringes.

Lilly and Novast aren't the only ones hiring, others are hiring too! Check it out! Lilly and Novast Announce Ground Breaking of State of the Art Manufacturing Facility Expansion in Nantong, China NANTONG, China, March 5, 2014 /PRNewswire/ -- Lilly and Novast Laboratories Ltd. , today announced that they have commenced the expansion of manufacturing ... (more)

The complete response letter referenced previously observed deficiencies at a Boehringer Ingelheim facility where empagliflozin will be manufactured.